To assess the understanding, perceptions, and practices of PICU physicians in China regarding prophylactic anti-seizure medication (ASM) for pediatric traumatic brain injury (TBI).
Approach:
Key Findings:
94.8% of surveyed physicians referred to the Chinese Expert Consensus for managing pediatric TBI.
72.7% reported using prophylactic ASM.
Primary decision factors for ASM use included guidelines (46.9%), clinical expertise (27.3%), and neurosurgeon consultation (18.2%).
Prophylactic ASM use varied by years of experience and professional title.
Interpretation:
The study highlights a significant reliance on expert consensus and varying practices among PICU physicians regarding prophylactic ASM for pediatric TBI.
Limitations:
The study's findings may not be generalizable beyond the surveyed hospitals.
Potential biases in self-reported data from physicians.
Conclusion:
The findings aim to inform improvements in clinical strategies for managing post-traumatic seizures in pediatric patients.
